CT衍生的非心血管钙化标志物在糖尿病老年人中预测心血管事件的应用:动脉粥样硬化多种族研究
在动脉粥样硬化多种族研究中,≥65岁且糖尿病病程≥5年的231例患者与1148例非糖尿病者相比,随访8.7年间心血管病事件发生率分别为17%和11%。在长期糖尿病患者中,冠状动脉钙化评分加倍与心血管病风险升高相关(HR 1.13),加入肋软骨钙化后模型C统计量从0.66提高到0.69。
要点
- 在长期糖尿病老年人中,冠状动脉钙化评分加倍与心血管病风险升高相关(HR 1.13,95%CI 1.01-1.26)。
- 加入肋软骨钙化后,心血管病预测模型C统计量从0.66提高到0.69(p=0.02)。
- 肋软骨钙化可从常规CT利用现有冠状动脉钙化评估工具测量,有助于风险分层。
核心结论
- 肋软骨钙化是可从任何常规CT测量的非心血管钙化生物标志物,能改善长期糖尿病老年人心血管病和冠心病风险预测模型的性能。
研究设计与样本
- 动脉粥样硬化多种族研究的事后分析,纳入≥65岁长期糖尿病(病程≥5年,n=231)患者与非糖尿病参与者(n=1148)比较。
诊断标准与关键数值
- 在长期糖尿病患者中,冠状动脉钙化评分加倍与心血管病风险升高相关(HR 1.13;95%CI 1.01-1.26)。
- 在长期糖尿病患者中,冠状动脉钙化评分加倍与冠心病风险相关(HR 1.05;95%CI 0.98-1.13)。
- 在长期糖尿病患者中,加入肋软骨钙化后心血管病模型C统计量从0.66提高到0.69(p=0.02)。
- 在长期糖尿病患者中,加入肋软骨钙化后冠心病模型C统计量从0.65提高到0.69(p=0.04)。
- 在非糖尿病参与者中,加入肋软骨钙化未改善心血管病或冠心病模型性能(p>0.5)。
临床应用与阅片要点
- 肋软骨钙化可利用现有冠状动脉钙化评估工具在CT扫描上轻松测量,将其纳入心血管风险评估可能改善长期糖尿病老年人的临床决策和个体化风险分层。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To evaluate the discriminative power of coronary artery calcium (CAC) score-based Cox models for predicting cardiovascular disease (CVD) in older adults with longstanding diabetes, a population at elevated CVD risk. We also aimed to determine whether adding computed tomography (CT)-derived costal cartilage calcification (CCC) improves risk prediction, given the potential limitation of CAC due to widespread soft tissue calcification.
MATERIALS AND METHODS: We analyzed adults ≥ 65 years from the multi-ethnic study of atherosclerosis with longstanding diabetes mellitus (DM, ≥ 5 years, n = 231) and compared them to non-DM participants (n = 1148). We evaluated CAC-based risk models (adjusted for Framingham Risk Score, race/ethnicity, and statin use) and assessed the impact of adding CCC on model performance using Cox proportional-hazards regression and Harrell's C-statistic to predict CVD and coronary heart disease (CHD) incidence. CHD events included fatal coronary events, resuscitated cardiac arrest, myocardial infarction, adjudicated angina, and revascularization with angina. CVD events encompassed CHD, stroke (excluding transient ischemic attack), cardiovascular death, or other atherosclerotic deaths.
RESULTS: Over 8.7 years, CVD and CHD events occurred in 17% and 10% of DM participants and 11% and 5% of non-DM participants, respectively. In longstanding DM participants, doubling of CAC was associated with higher CVD risk (HR: 1.13; 95% CI: 1.01-1.26), with model discrimination improving from C-statistic 0.66 to 0.69 (p = 0.02) after adding CCC. For CHD, the corresponding HR was 1.05 (95% CI: 0.98-1.13), and the C-statistic rose from 0.65 to 0.69 (p = 0.04). In non-DM participants, CCC did not enhance model performance for either CVD or CHD (p > 0.5).
CONCLUSION: CCC, a measurable biomarker of non-cardiovascular calcification from any conventional CT, improves CVD and CHD risk prediction models' performance in older adults with longstanding DM.
KEY POINTS: Question Coronary artery calcium (CAC) may have limited discriminative power for predicting cardiovascular outcomes in older adults with longstanding diabetes. Findings Costal cartilage calcification (CCC), a biomarker of non-cardiovascular calcification from CT, improves the prediction of cardiovascular disease and coronary heart disease risks in this population. Clinical relevance Incorporating CCC, which can be easily measured using existing CAC assessment tools on CT scans, into cardiovascular risk assessment could refine clinical decision-making and improve individualized risk stratification in older adults with longstanding diabetes.
引用
- Ghotbi E, Bluemke DA, Hathaway QA, et al. Use of CT-derived non-cardiovascular calcification marker for predicting cardiovascular events among diabetic older adults: the multi-ethnic study of atherosclerosis. Eur Radiol. 2025. PMID: 40782222. doi:10.1007/s00330-025-11778-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。